drugset / Trial / NCT03390166
Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults
Phase 2/3
Completed
945 enrolled
Mahidol University
The Government Pharmaceutical Organization · collabWorld Health Organization · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The study is aim to evaluate the immunogenicity and safety with two groups of participants who will received a seasonal trivalent split, inactivated influenza vaccine (A/H1N1; A/H3N2 and B) or an active comparator (licensed influenza vaccine
Timeline
- Start
- 2017-07-24
- Primary completion
- 2018-03-31
- Completion
- 2019-02-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Licensed influenza vaccine | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Tri Fluvac | Vaccine | — | Intramuscular |